Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

GSK names Emma Walmsley as new chief executive

LONDON – Drugmaker GlaxoSmithKline says Emma Walmsley will be the company’s new chief executive, replacing Andrew Witty when he retires next March.

Walmsley currently runs the company’s consumer healthcare division, established as part of a deal in which GSK swapped its cancer-drug unit for Novartis’s vaccine business.

She joined GSK in 2010 from L’Oreal, where she held roles in the U.K., Europe and China.

Walmsley says Tuesday that GSK has momentum and “the opportunity and the potential to create meaningful benefits for patients, consumers and our shareholders.”

GSK and other large pharmaceutical companies are regrouping amid competition from generic drugmakers, shedding units that aren’t central to their businesses and focusing on their strengths.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles